Immunostaining of Day92 cerebral organoid shows the presence of TH and MAP2 positive neurons. TH: used as cell marker of dopaminergic neurons. MAP2: mature neuron cell marker.
产品类型 | 货号 | 产品描述 |
---|---|---|
Cerebral Organoid | CIPO-BWL001K | Ready-to-use Human iPSC-Derived Cerebral Organoids |
CIPO-BWL001KC | Cryopreserved Human iPSC-Derived Cerebral Organoids | |
RIPO-BWM001K | Human iPSC-Derived Cerebral Organoid Differentiation Kit | |
RIPO-BWM003 | Human iPSC-Derived Cerebral Organoid Maturation and Maintenance Kit | |
RIPO-BWM006 | Cerebral Organoid Cryopreservation Kit |
The cardiac organoids differentiated using the Human iPSC-Derived Cardiac Organoid Differentiation Kit (Ca. No. RIPO-HWM002K) show regular beating from day 7-13 of differentiation.
产品类型 | 货号 | 产品描述 |
---|---|---|
Cardiac Organoid | CIPO-HWL002K | Ready-to-use Human iPSC-Derived Cardiac Organoids |
RIPO-HWM002K | Human iPSC-Derived Cardiac Organoid Differentiation Kit | |
RIPO-HWM004 | Human iPSC-Derived Cardiac Organoid Maintenance Kit | |
RIPO-HWM005 | Cardiac Organoid Cryopreservation Kit |
The intestinal organoids differentiated using the Human iPSC-Derived intestinal Organoid Differentiation Kit (Ca. No. RIPO-IWM005K) show regular peristalsis.
产品类型 | 货号 | 产品描述 |
---|---|---|
肠道类器官 | CIPO-IWL003K | Ready-to-use Human iPSC-Derived Intestinal Organoids |
RIPO-IWM005K | Human iPSC-Derived Intestinal Organoid Differentiation Kit | |
RIPO-IWM006 | Human iPSC-Derived Intestinal Organoid Maintenance Kit |
The Liver Organoids (Cat. No. CIPO-RWL005K) differentiated by using the Human iPSC-Derived Liver Organoid Differentiation Kit (Cat. No. RIPO-RWM009K) expressed hepatic marker (ALB), cholangiocyte marker (CK19) and endothelial marker (CD31) at day 34. (Scale bar: 250μm).
产品类型 | 货号 | 产品描述 |
---|---|---|
肝脏类器官 | CIPO-RWL005K | Ready-to-use Human iPSC-Derived Liver Organoids |
RIPO-RWM009K | Human iPSC-Derived Liver Organoid Differentiation Kit | |
RIPO-RWM010 | Human iPSC-Derived Liver Organoid Maintenance Kit |
> 心脏类器官分化
> 大脑类器官分化
您可以提供组织样本或iPSC细胞系由我们进行类器官开发。目前,我们已有组织来源的血管类器官的成功服务案例。
可打造试剂或致病蛋白(如PFFs)以及基因编辑诱导的疾病模型。我们目前正在开发的疾病模型包括AD、PD、IBD、神经炎症和血脑屏障。
可提供基于细胞和类器官的综合毒性和有效性检测服务。目前我们拥有基于电生理学的检测平台和免疫检测平台。